← All trials
NCT05753371
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 23, 2022
- Primary completion
- Mar 24, 2022
- Completion date
- Mar 31, 2022
- First posted
- Mar 3, 2023
- Last posted
- Mar 3, 2023
- Enrollment
- 24
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- PT. Pyridam Farma TbkLead sponsor
- PT Pharma Metric LabsCollaborator
- PT Pharma Metric LabsOverall official - principal investigator
- PT Pharma Metric LabsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.